# FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer

> **NCT02226380** · PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 75 (estimated)

## Conditions studied

- Gastric Cancer
- Effects of Chemotherapy
- Surgery

## Interventions

- **DRUG:** mFOLFOX6 regimen

## Key facts

- **NCT ID:** NCT02226380
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2014-12
- **Final completion:** —
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2014-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02226380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02226380, "FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02226380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*